National Cancer Institute; Notice of Closed Meetings, 6872-6873 [2016-02534]
Download as PDF
<![CDATA[
6872
Federal Register / Vol. 81, No. 26 / Tuesday, February 9, 2016 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Complementary &
Integrative Health; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Complementary and Integrative Health
Special Emphasis Panel; TRAINING.
Date: March 17, 2016.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Martina Schmidt, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Center for Complementary
& Integrative Health, NIH, 6707 Democracy
Blvd., Suite 401, Bethesda, MD 20892, 301–
594–3456, schmidma@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.213, Research and Training
in Complementary and Alternative Medicine,
National Institutes of Health, HHS)
Dated: February 3, 2016.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–02459 Filed 2–8–16; 8:45 am]
BILLING CODE 4140–01–P
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, Investigator Initiated
Extended Clinical Trial (R01).
Date: March 2, 2016.
Time: 10:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892,
(Telephone Conference Call).
Contact Person: Zhuqing (Charlie) Li,
Ph.D., Scientific Review Officer, Scientific
Review Program, Division of Extramural
Activities, Room # 3G41B National Institutes
of Health/NIAID, 5601 Fishers Lane,
MSC9823, Bethesda, MD 20892–9823, (240)
669–5068, zhuqing.li@nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, NIAID Investigator Initiated
Program Project Applications (P01).
Date: March 3, 2016.
Time: 1:30 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Room
4C100, 5601 Fishers Lane, Rockville, MD
20892 (Telephone Conference Call).
Contact Person: Uday K. Shankar, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
Room # 3G21B, National Institutes of Health,
NIAID, 5601 Fishers Lane, MSC 9823,
Bethesda, MD 20892–9823, (240) 669–5051,
uday.shankar@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: February 4, 2016
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–02532 Filed 2–8–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
mstockstill on DSK4VPTVN1PROD with NOTICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
VerDate Sep<11>2014
17:54 Feb 08, 2016
Jkt 238001
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Heart, Lung, and
Blood Initial Review Group; NHLBI
Mentored Transition to Independence
Review Committee.
Time: March 3–4, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The William F. Bolger Center, 9600
Newbridge Drive, Potomac, MD 20854.
Contact Person: Giuseppe Pintucci, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7192, Bethesda, MD 20892, 301–435–0287,
Pintuccig@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: February 3, 2016.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–02457 Filed 2–8–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of meetings of the Board of
Scientific Counselors for Basic Sciences,
National Cancer Institute and the Board
of Scientific Counselors for Clinical
Sciences and Epidemiology, National
Cancer Institute.
The meetings will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Cancer Institute, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
E:\FR\FM\09FEN1.SGM
09FEN1
Federal Register / Vol. 81, No. 26 / Tuesday, February 9, 2016 / Notices
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors for Basic Sciences, National
Cancer Institute.
Date: March 7, 2016.
Time: 9:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health, 31
Center Drive, Building 31, C-Wing, 6th Floor,
Conference Room 6, Bethesda, MD 20892.
Contact Person: Mehrdad Tondravi, Ph.D.,
Chief, Institute Review Office, Office of the
Director, National Cancer Institute, National
Institutes of Health, 9609 Medical Center
Drive, Room 3W302, Rockville, MD 20850,
240–276–5660, tondravim@mail.nih.gov.
Name of Committee: Board of Scientific
Counselors for Clinical Sciences and
Epidemiology, National Cancer Institute.
Date: March 8, 2016.
Time: 8:30 a.m. to 4:30 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health, 31
Center Drive, Building 31, C Wing, 6th Floor,
Conference Room 6, Bethesda, MD 20892.
Contact Person: Brian E. Wojcik, Ph.D.,
Executive Secretary, Institute Review Office,
Office of the Director, National Cancer
Institute, National Institutes of Health, 9609
Medical Center Drive, Room 3W414,
Rockville, MD 20850, 240–276–5660,
wojcikb@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: February 4, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–02534 Filed 2–8–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
mstockstill on DSK4VPTVN1PROD with NOTICES
National Institute on Alcohol Abuse
and Alcoholism; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
VerDate Sep<11>2014
17:54 Feb 08, 2016
Jkt 238001
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Special
Emphasis Panel; NIAAA Member Conflict
Applications—Neurosciences.
Date: March 11, 2016.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health—
NIAAA, 5635 Fishers Lane, Rockville, MD
20892, (Telephone Conference Call).
Contact Person: Ranga Srinivas, Ph.D.,
Chief, Extramural Project Review Branch,
National Institute on Alcohol Abuse and
Alcoholism, National Institutes of Health,
5365 Fishers Lane, Room 2085, Rockville,
MD 20852, (301) 451–2067, srinivar@
mail.nih.gov.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Special
Emphasis Panel; NIAAA Member Conflict
Applications—Clinical, Behavioral and
Epidemiological Studies.
Date: March 14, 2016.
Time: 11:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health—
NIAAA, 5635 Fishers Lane, Rockville, MD
20892 (Telephone Conference Call).
Contact Person: Ranga Srinivas, Ph.D.,
Chief, Extramural Project Review Branch,
National Institute on Alcohol Abuse and
Alcoholism, National Institutes of Health,
5365 Fishers Lane, Room 2085, Rockville,
MD 20852, (301) 451–2067, srinivar@
mail.nih.gov.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Special
Emphasis Panel; NIAAA Member Conflict
Applications—Biomedical Sciences.
Date: March 16, 2016.
Time: 2:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health—
NIAAA, 5635 Fishers Lane, Rockville, MD
20852, (Telephone Conference Call).
Contact Person: Ranga Srinivas, Ph.D.,
Chief, Extramural Project Review Branch,
National Institute on Alcohol Abuse and
Alcoholism, National Institutes of Health,
5365 Fishers Lane, Room 2085, Rockville,
MD 20852, (301) 451–2067, srinivar@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271, Alcohol Research
Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 93.273, Alcohol Research Programs;
93.891, Alcohol Research Center Grants;
93.701, ARRA Related Biomedical Research
and Research Support Awards., National
Institutes of Health, HHS)
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
6873
Dated: February 4, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–02539 Filed 2–8–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
The Use of Chimpanzees in NIHSupported Research
This notice provides
information on the National Institutes of
Health’s (NIH) reassessment of the need
to maintain a colony of 50 chimpanzees
for future research and decision to no
longer maintain a chimpanzee colony
for research. This notice also provides
information on conforming updates and
procedures related to this action.
FOR FURTHER INFORMATION CONTACT: The
Division of Program Coordination,
Planning, and Strategic Initiatives,
Office of the Director, National
Institutes of Health at dpcpsi@
od.nih.gov.
SUMMARY:
On
November 18, 2015, the NIH announced
it will no longer maintain a colony of 50
chimpanzees for future research and
that all NIH-owned chimpanzees that
reside outside the federal sanctuary
system operated by Chimp Haven,
Keithville, Louisiana, are eligible for
retirement. Relocation of the
chimpanzees to the federal sanctuary
system will be conducted as space is
available and on a timescale that will
allow for optimal transition of each
individual chimpanzee with careful
consideration of their welfare, including
their health and social grouping. See the
NIH Director’s statement at https://www.
nih.gov/about-nih/who-we-are/nihdirector/statements/nih-will-no-longersupport-biomedical-researchchimpanzees. Consistent with this
decision, the NIH is limiting its future
support for research using chimpanzees
to that which would be permissible in
the federal sanctuary system under the
Chimpanzee Health Improvement,
Maintenance and Protection (CHIMP)
Act and the implementing regulations at
42 CFR part 9. Such research must
either be noninvasive behavioral studies
or medical studies based on information
collected during the course of normal
veterinary care that is provided for the
benefit of the chimpanzee, provided that
any such study involves minimal
physical and mental harm, pain,
distress, and disturbance to the
SUPPLEMENTARY INFORMATION:
E:\FR\FM\09FEN1.SGM
09FEN1
]]>Agencies
[Federal Register Volume 81, Number 26 (Tuesday, February 9, 2016)]
[Notices]
[Pages 6872-6873]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-02534]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of meetings of the
Board of Scientific Counselors for Basic Sciences, National Cancer
Institute and the Board of Scientific Counselors for Clinical Sciences
and Epidemiology, National Cancer Institute.
The meetings will be closed to the public as indicated below in
accordance with the provisions set forth in section 552b(c)(6), Title 5
U.S.C., as amended for the review, discussion, and evaluation of
individual intramural programs and projects conducted by the National
Cancer Institute, including consideration of personnel qualifications
and performance, and the competence of individual investigators, the
disclosure of which would
[[Page 6873]]
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Board of Scientific Counselors for Basic
Sciences, National Cancer Institute.
Date: March 7, 2016.
Time: 9:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate personal qualifications and
performance, and competence of individual investigators.
Place: National Institutes of Health, 31 Center Drive, Building
31, C-Wing, 6th Floor, Conference Room 6, Bethesda, MD 20892.
Contact Person: Mehrdad Tondravi, Ph.D., Chief, Institute Review
Office, Office of the Director, National Cancer Institute, National
Institutes of Health, 9609 Medical Center Drive, Room 3W302,
Rockville, MD 20850, 240-276-5660, tondravim@mail.nih.gov.
Name of Committee: Board of Scientific Counselors for Clinical
Sciences and Epidemiology, National Cancer Institute.
Date: March 8, 2016.
Time: 8:30 a.m. to 4:30 p.m.
Agenda: To review and evaluate personal qualifications and
performance, and competence of individual investigators.
Place: National Institutes of Health, 31 Center Drive, Building
31, C Wing, 6th Floor, Conference Room 6, Bethesda, MD 20892.
Contact Person: Brian E. Wojcik, Ph.D., Executive Secretary,
Institute Review Office, Office of the Director, National Cancer
Institute, National Institutes of Health, 9609 Medical Center Drive,
Room 3W414, Rockville, MD 20850, 240-276-5660, wojcikb@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: February 4, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-02534 Filed 2-8-16; 8:45 am]
BILLING CODE 4140-01-P
